Breast cancer, Secondary cancers
Results
Phase 2/3
This trial looked at adding buparlisib to paclitaxel for breast cancer that is HER2 negative. It was women whose breast cancer had:
spread into tissue surrounding the breast or to another part of the body (advanced cancer)
low or no amounts of HER2 (HER2 negative breast cancer)
Recruitment start: 15 August 2012
Recruitment end: 29 August 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Iain Macpherson
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 21 February 2019
CRUK internal database number: 9854
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
